Page results
-
This information has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the oesophagus (gullet).
-
This page has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the bronchus
-
If you need an assessment by a midwife or doctor that is outside of your routine antenatal appointments you will be invited to attend the Maternal and Fetal Assessment Unit (MFAU).
-
This patient information includes different relaxation techniques which patients being seen by the Post-COVID Service team may find useful.
-
Patient information leaflet for patients suffering form long COVID who are experiencing breathlessness or changes in their breathing pattern.
-
This provides information about a treatment for uterine fibroids known as ‘transcervical ultrasound-guided radiofrequency ablation’. You may also hear it called by the Manufacturer’s name ‘Sonata®’ for short.
-
A new trial led by UCLH and UCL is looking at whether music therapy can help patients recover from severe brain injury.
-
This page provides information about the thermoregulatory sweat test (TST).
-
Our new report shows the difference charitable funds can make to patients, staff and research at UCLH
-
This page provides information about the use of venous sinus stents in the treatment of venous sinus stenosis and idiopathic intracranial hypertension (IIH).
File results
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2019/16 Antenatal unit questionnaire
-
FOI2017320 Patients with Multiple Sclerosis treated with MS disease modifying drugs
-
FOI2017300 Sustainability and transformation
-
FOI2017315 Expenditure on reconciliation and validation of incomplete and missing RTT codes
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI2017328 Use of variable rate intravenous insulin infusion